Effect of Walker vs Wheeled Device on Mobility After Total Knee Arthroplasty
Launched by STANFORD UNIVERSITY · Oct 5, 2023
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different mobility devices can help people move better after having total knee replacement surgery, also known as total knee arthroplasty. The study compares a new tool called the A-Linker with the standard walker that many patients use for support. Researchers want to see if using the A-Linker can improve how easily and effectively patients can get around after their surgery.
To participate in this study, you need to be between 65 and 74 years old and scheduled to have total knee arthroplasty. If you’re eligible, you’ll have the chance to try out the A-Linker and see how it works for you compared to a traditional walker. The trial is currently looking for participants, and being part of it will help doctors understand the best ways to support recovery and improve mobility for patients after knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Receiving total knee arthroplasty
- Exclusion Criteria:
- • Not receiving total knee arthroplasty
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Redwood City, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported